MF. Sulfate and thiosulfate inhibit oxalate transport via a dPrestin (Slc26a6)-dependent mechanism in an insect model of calcium oxalate nephrolithiasis. Am J Physiol Renal Physiol 310: F152-F159, 2016. First published November 4, 2015 doi:10.1152/ajprenal.00406.2015-Nephrolithiasis is one of the most common urinary tract disorders, with the majority of kidney stones composed of calcium oxalate (CaOx). Given its prevalence (US occurrence 10%), it is still poorly understood, lacking progress in identifying new therapies because of its complex etiology. Drosophila melanogaster (fruitfly) is a recently developed model of CaOx nephrolithiasis. Effects of sulfate and thiosulfate on crystal formation were investigated using the Drosophila model, as well as electrophysiological effects on both Drosophila (Slc26a5/6; dPrestin) and mouse (mSlc26a6) oxalate transporters utilizing the Xenopus laevis oocyte heterologous expression system. Results indicate that both transport thiosulfate with a much higher affinity than sulfate Additionally, both compounds were effective at decreasing CaOx crystallization when added to the diet. However, these results were not observed when compounds were applied to Malpighian tubules ex vivo. Neither compound affected CaOx crystallization in dPrestin knockdown animals, indicating a role for principal cell-specific dPrestin in luminal oxalate transport. Furthermore, thiosulfate has a higher affinity for dPrestin and mSlc26a6 compared with oxalate These data indicate that thiosulfate's ability to act as a competitive inhibitor of oxalate via dPrestin, can explain the decrease in CaOx crystallization seen in the presence of thiosulfate, but not sulfate. Overall, our findings predict that thiosulfate or oxalate-mimics may be effective as therapeutic competitive inhibitors of CaOx crystallization.
sulfate; thiosulfate; oxalate; electrophysiology; transport; Slc26a6; kinetics; inhibition NEPHROLITHIASIS (kidney stones) is a major healthcare burden (Ͼ$10.3 billion/yr in US in 2012, i.e., one-third of National Institutes of Health budget) affecting ϳ12% of men and 6% of women during their lifetime in industrialized countries (2) . However, given its prevalence, it is still poorly understood at both the physiological and genetic levels because of its significant complexity and varied etiology. The most common type of human kidney stone is largely composed of calcium oxalate (CaOx), which likely results from a combination of environmental and genetic factors. Mutations affecting oxalate metabolism, cell membrane transporters, ion receptors, and transmembrane ion channels have led to CaOx stone manifestations in diseases such as Dent's disease, Bartter's syndrome, and hyperoxaluric metabolic disease (14) .
Recently, our laboratory developed a useful genetic model in Drosophila melanogaster, where major renal pathophysiology (CaOx kidney stones), particularly cation/anion movement, can be studied rather precisely (7) . Additionally, we identified a key transporter, Drosophila prestin (Slc26a5/6; dPrestin) that participates in this process (7) . dPrestin has been shown to mediate electrogenic Cl Ϫ /oxalate 2Ϫ , Cl Ϫ /sulfate 2Ϫ , and electroneutral Cl Ϫ
/formate
Ϫ exchange similar to what we and others have reported for other species orthologs of Slc26a6 (4, 6, 7, 9 -12, 15, 24, 26) . Interestingly, this transporter serves as a homolog to mouse Slc26a6 (mSlc26a6), whereby mice lacking this protein present with renal and intestinal transport defects in addition to CaOx urolithiasis (9, 24) . Our model has shown that Drosophila can specifically mimic CaOx crystal formation, gut and renal tubule Cl Ϫ /ox 2Ϫ exchange, and whole animal gut oxalate absorption to CaOx crystal formation compared with mammalian models (3, 5, 7) . These data also provide additional evidence illustrating dPrestin as a homolog of mammalian Slc26a6 function in the pathophysiology of CaOx renal stone formation (3, 5, 7) . Previous reports showed that dPrestin and mSlc26a6 exhibit sulfate-dependent currents (7, 11) . However, unlike mSlc26a6, the steady-state kinetics of dPrestin-mediated sulfate transport has not been reported.
The sulfates, particularly thiosulfate, have a number of medical uses, such as an antidote to cyanide poisoning and concurrent administration with cisplatin to decrease nephrotoxicity (16) . Interestingly, thiosulfate is reported as a treatment strategy for recurrent calcium nephrolithiasis. In 1985, Yatzidis (28) suggested that thiosulfate could reduce urinary ionized calcium levels, thereby decreasing rates of nephrolithiasis. In 1994, Agroyannis (1) reported that a patient receiving thiosulfate for treatment of renal tubular acidosis type I with nephrocalcinosis had no worsening of renal function and remained without clinical symptoms. Asplin and colleagues (2) reported that thiosulfate administration significantly reduced spontaneous calcium phosphate stone formation in genetic hypercalciuric stone (GHS)-forming rats (2) . More recently, Rodgers and coworkers (18) reported that sulfate but not thiosulfate decreased calculated urinary, ionized Ca 2ϩ and supersaturation in vitro and in silico. Given this information, it can be concluded that evidence for the use of sulfate and thiosulfate in humans and rat models of nephrolithiasis has a positive effectiveness correlation, but that the predicted mechanism of action does not match the experimental outcomes, i.e., decreases in urine ionized calcium.
Since there are different systems and apparent data conflicts, our studies were designed to test the roles of these sulfate compounds on oxalate transport, rather than urinary calcium, and subsequent CaOx crystallization. Given that our Drosophila model can be used to easily and rapidly study genetic and physiological factors, the current study sought to investigate the effects of sulfate and thiosulfate on both dPrestin (dSlc26a5/a6) and mSlc26a6 function as potential inhibitors of transport, as well as CaOx crystallization in Drosophila Malpighian tubules (MT).
MATERIALS AND METHODS
Drosophila. Flies were kept on standard medium or dietary salt substitution in vials at 22°C, 12:12-h photoperiod, and 40% relative humidity. Wild-type (Oregon R) flies were used in ex vivo and whole fly feeding experiments, except where noted.
Ex vivo oxalate Ϯ inhibitor birefringence experiments. Adult flies (7d) were allowed to feed on standard food. Malpighian tubules (MT) from female flies were dissected in Schneider's medium and transferred immediately to poly-L-lysine-coated slides with insect PBS containing either 20 mmol/l sulfate or 20 mmol/l thiosulfate and allowed to preincubate for 20 min. An inhibitor containing PBS was then aspirated and replaced with PBS containing 5 mmol/l Na-oxalate and either 20 mmol/l sulfate or 20 mmol/l thiosulfate. These were allowed to coincubate for 1 h with fresh solution replaced every 15 min. Crystallization was monitored for 60 min with a Zeiss Observer microscope using differential interference contrast (DIC) microscopy as previously (7) .
Cell type-specific knockdown of dPrestin. This was performed as described previously (7) . Briefly, the GAL4/UAS system allows for cell-and/or tissue-specific genetic manipulation in Drosophila, whereby a fly line which possesses a "GAL4-driver" can be crossed to a second transgenic fly line containing a construct of choice placed downstream of a UAS promoter. This allows the transgene to only be expressed in those cells and/or tissues where GAL4 is also expressed. To specifically knock down dPrestin, we utilized the Uro-GAL4 driver, whereby the promoter of the tubule principal cell-specific gene urate oxidase (Uro) drives GAL4 expression, and crossed it to the BIGFly line 5843R3 (National Institute of Genetics) containing a hairpin dsRNA sequence directed against dPrestin.
Feeding oxalate Ϯ inhibitor birefringence experiments. Adult flies were placed on food containing 5 mmol/l Na-oxalate and either 20 mmol/l sulfate or 20 mmol/l thiosulfate and were allowed to feed for 24 or 48 h. We chose 20 mM sulfate and thiosulfate based on our V max data (Fig. 2) . We also wanted to make sure that we used the same molar additive to our fly food to minimize the possibility of ion concentration effects. At each respective time point, MT were dissected (above) and transferred to coated slides with insect PBS. Tubules were imaged immediately with a Zeiss Observer microscope using DIC microscopy as previously (7).
CaOx crystal quantitation. CaOx crystals were quantified using ImageJ software. Pictures were ϫ10 magnification, and the scale was set to reflect the full length of the image obtained as above. Six hundred micrometers were measured from the terminal end of the respective MT and quantified to achieve consistency among pictures. Once measured, brightness and contrast were adjusted, resulting in only birefringent crystals in the designated 600 m of tubule being visible, and the remaining tubule artifacts were blacked out. A threshold was then set, resulting in binary coloration (black and white) so that crystals could be counted. Using the Analyze Particles feature in ImageJ, the minimum desired size of stone detection was specified at 2 m 2 , and parameters were set to overlay masks, display results, summarize, and to include holes. Data generated included an accurate and specific crystal count, total area of the 600 m of tubule containing crystals, and the average size per individual crystal in said area. Data were then analyzed via one-way ANOVA with Dunnett's post hoc test (P Ͻ 0.05) or Student's t-test (P Ͻ 0.05) using GraphPad Prism.
Animal health and welfare. X. laevis were housed and cared for in accordance and approval of the Institutional Care and Use Committees of the Mayo Clinic College of Medicine.
Drosophila Slc26a5 constructs. The sequence of dPrestin (Slc26a5; CG5485) has been previously reported (25) . As reported previously (7), we amplified this sequence by PCR, verified the sequence, and functionally tested the resulting clone. Our experiments indicate that dPrestin (CG5485) is the functional homolog of mammalian Slc26a6 (7) and is molecularly more closely aligned with Slc26a6 clones (8) .
Oocyte experiments. dPrestin as well as mSlc26a6 were subcloned into the pGEMHE Xenopus expression vector, capped cRNA synthesized. Oocytes were injected with 50 nl cRNA (0.2 g/l, 10 ng/oocyte) or water as previously for other transporters (7, 11, 17, 19, 20) and incubated at 16°C in OR 3 media. Oocytes were studied 3-10 days after injection.
Electrophysiology. Electrophysiology protocols were performed as we previously reported for Slc26a6 (8, 11, 12, 26) . All solutions were either ND96 (96 mM NaCl, 2 mM KCl, 1.8 mM CaCl 2, 1 mM MgCl2, 5 mM HEPES, pH 7.5) or isosmotic ion replacements (21) . Kinetic experiments were done with the addition of either increasing sulfate (0, 0.185, 0.556, 1.67, 5, and 15 mM) or thiosulfate (0, 0.0206, 0.0617, 0.185, 0.556, 1.667, and 5 mM). Cl Ϫ ND96 solutions (20 and 70 mM) were prepared as previously described (11) .
Two-electrode voltage clamp. For these experiments, membrane currents were recorded with an OC-725C voltage clamp (Warner Instruments, Hamden, CT), filtered at 2-5 kHz, and digitized at 10 kHz. Current-voltage protocols consisted of 40-ms steps from V h (Ϫ60 mV) to Ϫ140 mV and ϩ60 mV in 20-mV steps (11, 21) .
RESULTS
dPrestin and mSlc26a6 transport sulfate and thiosulfate. To examine sulfate and thiosulfate transport function, dPrestin and mSlc26a6 proteins were expressed separately in Xenopus oocytes. Figure 1 shows two-electrode voltage-clamp experiments. Sulfate elicited slightly rectifying currents in both dPrestin-and mSlc26a6-expressing oocytes, whereas thiosulfate elicited outwardly rectifying current only in mSlc26a6-expressed oocytes. Control (water-injected) oocytes do not show these responses. The dPrestin-mediated sulfate activity (Fig. 1A) is similar to our previous report (7) . Thiosulfate, however, was transported by both dPrestin and mSlc26a6 with similar current magnitudes (Fig. 1B) . These data indicate that thiosulfate is another substrate for both transporters, but is not merely a sulfate substitute.
Next, we determined the affinity of dPrestin and mSlc26a6 for sulfate and thiosulfate (Fig. 2) . To do this, we used a voltage clamp and measured the current responses (kinetics) to Fig. 2 show that in the presence of 20 mM Cl Ϫ , both dPrestin and mSlc26a6 have, on average, a 7-8 fold higher affinity for thiosulfate (Fig. 2, A and B) than for sulfate (Fig. 2,  C and D) . The average K m (average from all voltages) for sulfate transport via dPrestin is 8.65 Ϯ 3.87 mM, which is about eightfold higher than for thiosulfate (0.23 Ϯ 0.03 mM). However, since both dPrestin and mSlc26a6 are electrogenic transporters, the K m values are more appropriately stated at specific clamping voltages ( Fig. 2E ; Table 1 ). Transport of both sulfate compounds follow the same overall pattern for mSlc26a6 transport (Fig. 2, B and D) with average K m values for sulfate (7.99 Ϯ 4.05 mM) also about eightfold higher than those for thiosulfate (1.27 Ϯ 0.22 mM). These results indicate that both transporters have a higher affinity to transport thiosulfate rather than sulfate. Similarly, for thiosulfate the voltage-dependent K m values are reported in Fig. 2E and Table 1 .
CaOx crystallization in Drosophila fed oxalate Ϯ sulfate or thiosulfate is significantly reduced by 48 h. After measuring transporter kinetics, we examined the effect of sulfate and thiosulfate on the formation of CaOx crystals in Drosophila MT both through feeding and ex vivo exposure (Fig. 3A) . Flies fed oxalate (5 mM)ϩthiosulfate (20 mM) showed significant decreases in CaOx crystal number and total crystal area at both time points (24 and 48 h) compared with oxalate alone (Fig.  3B) . Flies fed oxalate (5 mM)ϩsulfate (20 mM) showed a significant decrease in crystal number and total area only at the later time point (48 h) compared with oxalate alone. In contrast, when anterior MT were dissected and exposed to the same conditions ex vivo, there were no significant decreases in crystal number, total area, or size of individual crystals (Fig.  3B) . These results indicate that both sulfate and thiosulfate have the ability to decrease CaOx crystallization when fed to flies over a 24-to 48-h period. Thiosulfate appears to be more effective at decreasing CaOx crystallization by 24 h, with sulfate taking 48 h to show any significant effect. Interestingly, these results were only observed in flies when they were fed experimental compounds and not seen ex vivo, indicating an important role for transport/transport inhibition at the level of the gut.
dPrestin knockdown in MT significantly reverses sulfate-and thiosulfate-induced prevention of CaOx crystallization at 48 h.
Knockdown of dPrestin (dsRNA directed against dPrestin) reduces MT-mRNA levels by ϳ70% (7). Since sulfate and thiosulfate both serve as competitive inhibitors of dPrestinmediated oxalate transport and can prevent CaOx crystallization at 48 h, we examined the effect of these compounds on the formation of CaOx crystals in Drosophila MT with RNAi interference-mediated dPrestin knockdown (Fig. 4A) . Flies fed oxalate (5 mM)ϩthiosulfate (20 mM) or sulfate (20 mM) with dPrestin knockdown showed a significant increase in crystal number (Fig. 4B ) and total crystal area (Fig. 4C) , reversing those effects observed in MT with dPrestin expressed. These effects were also noted in terms of average size per crystal, but were only significant with oxalate and thiosulfate addition (Fig.  4D) . These results indicate that sulfate and thiosulfate competitively inhibit oxalate transport via luminal dPrestin in the MT and that with no dPrestin expression both compounds lose their abilities to effectively decrease CaOx crystallization.
DISCUSSION
Drosophila melanogaster has emerged as a useful model in exploring the pathophysiology of CaOx nephrolithiasis (3, 5, 7, 8) . Our previous experiments illustrated that renal tubule oxalate export is mediated by the Slc26a6 ortholog dPrestin, which can also transport sulfate (7, 8) . To better understand the factors determining CaOx crystallization and how sulfaterelated substrates may interact with oxalate transport and subsequent CaOx crystallization, we investigated the effects of sulfate and thiosulfate on CaOx crystallization in Drosophila MT as well as solute transport by dPrestin and mSlc26a6. We measured the apparent affinity (K m ) of dPrestin and mSlc26a6 to transport these compounds as putative proteins significantly involved in the epithelial movement of oxalate and subsequent CaOx crystal formation. Dose-dependent CaOx crystal formation is visible as early as 24 -48 h in the MT of flies fed increasing concentrations of sodium oxalate, and 14 days in flies fed increasing concentrations of ethylene glycol, hydroxyl-L-proline, or melamine (3, 7, 14) . The dPrestin gene model of nephrolithiasis was developed by selective knockdown of Slc26a6 known to be a luminal oxalate transporter in MT (7, 14) . Nine homologs of the 11 human Slc26 transporters are contained within the Drosophila genome, with the "prestin" gene encoding the functional ortholog of mammalian Slc26a6 (7, 14) . These transporter homologs in Drosophila are found in various tissues, with the highest expression patterns located within the MT, midgut, and hindgut (flyatas.org, query "cg5485"). Interestingly, like the human and mouse Slc26a6, dPrestin mediates Cl Ϫ /oxalate exchange (8) . Preliminary studies from our laboratory demonstrate that this model can be used to rapidly study factors which may influence CaOx crystallization within the MT (13, 22, 23) . Additionally, given that the nucleation and subsequent growth of the crystals can be observed in real time and in an intact MT, this MT model provides a powerful tool for assessing enhancers or inhibitors of CaOx crystallization.
The current study was designed to evaluate sulfate and thiosulfate transport by dPrestin and mSlc26a6, as well as to determine whether these compounds affected CaOx crystallization in MT. dPrestin and mSlc26a6 have been shown to transport sulfate, with steady-state kinetics being reported for mSlc26a6 having an average K m of 12.7 Ϯ 5.9 mM in the presence of 70 mM Cl Ϫ (8). However, these kinetic parameters of sulfate transport via dPrestin have not been reported. Before this study, neither thiosulfate transport nor kinetics via dPrestin or mSlc26a6 have been reported. Our results indicate that dPrestin and mSlc26a6 transport both sulfate and thiosulfate, with a 7-8-fold greater affinity for thiosulfate. This transport is of particular interest as thiosulfate administration reduced the occurrence of calcium urolithiasis (27) , and thiosulfate is used as a treatment for calcium phosphate nephrolithiasis (2) and nephrocalcinosis (1). Rodgers and coworkers (18) reported that sulfate, but not thiosulfate, had a modest effect of reducing urinary ionized calcium concentration, and concomitantly reducing urinary supersaturation of calcium salts, such as CaOx. Thiosulfate unfavorably increased CaOx supersaturation (18) . This study also concluded that the unfavorable increase in CaOx supersaturation was due to decrements in urine pH following thiosulfate ingestion, rather than urinary thiosulfate concentrations. However, none of these studies were able to test mechanisms, other than ionized calcium and supersaturation, which may affect thiosulfate's ability to decrease nephroand urolithiasis, particularly at concentrations which do not affect urinary pH. In the hindgut, dPrestin is thought to transport oxalate from the gut lumen into the cell, and in return transports chloride into the luminal space (A). Intracellular oxalate is then transported into the hemoceole, and subsequently into the MT principal cell via unknown mechanisms. It is here in the principal cell that intracellular oxalate is exchanged for a chloride anion via dPrestin and is transported into the luminal space of the MT, where it is available to complex with calcium, forming insoluble CaOx crystals and manifesting as CaOx nephrolithiasis (B). Additionally, if MT-specific dPrestin is knocked down, CaOx crystallization, even in the presence of sulfate or thiosulfate, mimics that of oxalate only controls (C and D). Sulfate and thiosulfate competitively inhibit oxalate transport via dPrestin most likely in the gut and definitely in the MT, effectively preventing oxalate from complexing with calcium, ultimately facilitating its noncomplexed excretion.
Our results indicate that thiosulfate is more effective at preventing CaOx crystallization at 24 and 48 h with both compounds being as effective at 48 h. These data seem most consistent with oxalate transport inhibition in the gut, rather than effects on CaOx supersaturation and/or urinary ionized calcium concentrations, as thiosulfate treatment of MT did not prevent crystallization. Thiosulfate K m values for both mammalian and Drosophila transporters are significantly lower than those for sulfate transport, indicating an increased affinity for thiosulfate explaining its effects at the earlier time point. Such an affinity increase implies that thiosulfate could act as a competitive inhibitor of oxalate at concentrations which should have no effect on ionized calcium or supersaturation ( we can assume that sulfate and thiosulfate are rendering the bulk of their competitive properties on gut dPrestin since MT-specific knockdown seems to have no effect on CaOx crystallization. Unfortunately, to our knowledge, there is no available, reliable gut cell-specific GAL4-driver; therefore, given these differences in CaOx crystallization observed in feeding vs. ex vivo, this conclusion is deductive rather than inclusive. Additionally, the Uro-GAL4 driver used to suppress the expression of luminally localized principal cell dPrestin is not significantly penetrant in the MT (ϳ50 -70%), especially in the terminal ends where the majority of calcium is stored, and hence where the majority of CaOx crystals are formed. This allows a portion of oxalate to still be secreted into the lumen by currently unknown mechanisms. In this case, CaOx crystallization still occurs, explaining why we still observe significant crystallization, especially when dPrestin knockdown is Uro-GAL4-driven. Given our MT-specific data, Fig. 5 postulates that sulfate and thiosulfate lessen CaOx crystallization via competitive interaction with oxalate at the level of the gut, thereby inhibiting transport out of the gut and/or into the lumen via a dPrestin-or mSlc26a6-dependent mechanism, subsequently and successfully preventing CaOx crystal formation and stone occurrence. Given our data, sulfate and thiosulfate are inhibiting oxalate transport at the luminal boundary of the MT since ex vivo exposure, which could allow oxalate to gain luminal access from ureter entry, had no effect. Hypothetically, by effectively competing with oxalate transport from the gut into the hemoceole and from the principal cell into the lumen, oxalate is prevented from accessing the calcium stores within the tubule lumen and is excreted uncomplexed via the gut pathway. However, the fact that CaOx crystals are still observed in tubules where dPrestin has been effectively knocked down indicates an alternative tubule oxalate secretion mechanism not further characterized in this study, but does indicate that the of action of sulfate and thiosulfate is competitive inhibition of oxalate via a dPrestin (mSlc26a6)-dependent mechanism.
This current study has investigated, as a proof of principle, the mechanism of sulfate-and thiosulfate-mediated inhibition of oxalate transport via dPrestin and mSlc26a6, as well as these compounds' effectiveness to limit CaOx crystallization within the MT via a dPrestin dependent-mechanism. Our findings thus far conclude that higher-affinity thiosulfate mimics or dPrestin/ mSlc26a6 oxalate mimics could be effective competitive inhibitors of CaOx crystallization and that this competition is most likely to involve luminal dPrestin in the gut, as well as luminal dPrestin in the MT, although other secretion mechanisms may exist. While blocking or limiting crystallization is an important step, it would be better yet to discover compounds capable of reversing CaOx crystallization.
